Matches in SemOpenAlex for { <https://semopenalex.org/work/W4243923897> ?p ?o ?g. }
Showing items 1 to 86 of
86
with 100 items per page.
- W4243923897 endingPage "507" @default.
- W4243923897 startingPage "499" @default.
- W4243923897 abstract "Ramipril, an angiotensin-converting enzyme (ACE) inhibitor for use in dogs, is converted in vivo to its active form, ramiprilat, which is eliminated in the bile and urine in the dog. The objective of this study was to assess the effect of renal impairment on the pharmacokinetics (PKs) and pharmacodynamics (PDs) of ramipril and ramiprilat. Ten adult Beagle dogs were used. PK/PD studies were performed before and after the induction of subclinical renal impairment. Ramiprilat was given at 0.25 mg/kg by a single IV bolus. After a 2-week washout period, ramipril was administered PO at 0.25 mg/kg once daily for 8 days. Ramipril and ramiprilat PKs were studied by using a physiologically based model. The relationship between free plasma ramiprilat concentration and ACE activity was described by using the fractional Hill model. Glomerular filtration rate was decreased by 58%. No biologically relevant changes in usual plasma variables were observed between the 1st and the 8th day of oral treatment with ramipril under either condition. After an IV bolus of ramiprilat, the only changes in renal-impaired dogs were a 14 and 49% decrease in clearance of the free fraction of ramiprilat (P <.01) and free plasma concentration required to produce 50% of the maximal effect (P <.05), respectively. After repeated PO administration of ramipril, there were no alterations in any of the PK and PD parameters in healthy or renal-impaired dogs. No adjustment of the recommended PO dosage of ramipril is needed in dogs with moderate renal impairment." @default.
- W4243923897 created "2022-05-12" @default.
- W4243923897 creator A5032572523 @default.
- W4243923897 creator A5040128812 @default.
- W4243923897 creator A5068757506 @default.
- W4243923897 creator A5089697453 @default.
- W4243923897 date "2006-05-01" @default.
- W4243923897 modified "2023-09-29" @default.
- W4243923897 title "Pharmacokinetic and Pharmacodynamic Parameters of Ramipril and Ramiprilat in Healthy Dogs and Dogs with Reduced Glomerular Filtration Rate" @default.
- W4243923897 cites W1966939913 @default.
- W4243923897 cites W1970886804 @default.
- W4243923897 cites W1978500857 @default.
- W4243923897 cites W2018331909 @default.
- W4243923897 cites W2031479489 @default.
- W4243923897 cites W2032587118 @default.
- W4243923897 cites W2037395856 @default.
- W4243923897 cites W2042294767 @default.
- W4243923897 cites W2047982942 @default.
- W4243923897 cites W2050789296 @default.
- W4243923897 cites W2052821578 @default.
- W4243923897 cites W2065891545 @default.
- W4243923897 cites W2066482395 @default.
- W4243923897 cites W2086182043 @default.
- W4243923897 cites W2087145240 @default.
- W4243923897 cites W2098698631 @default.
- W4243923897 cites W2129119242 @default.
- W4243923897 cites W2404007476 @default.
- W4243923897 cites W4211104668 @default.
- W4243923897 doi "https://doi.org/10.1111/j.1939-1676.2006.tb02888.x" @default.
- W4243923897 hasPublicationYear "2006" @default.
- W4243923897 type Work @default.
- W4243923897 citedByCount "5" @default.
- W4243923897 countsByYear W42439238972014 @default.
- W4243923897 countsByYear W42439238972017 @default.
- W4243923897 countsByYear W42439238972020 @default.
- W4243923897 crossrefType "journal-article" @default.
- W4243923897 hasAuthorship W4243923897A5032572523 @default.
- W4243923897 hasAuthorship W4243923897A5040128812 @default.
- W4243923897 hasAuthorship W4243923897A5068757506 @default.
- W4243923897 hasAuthorship W4243923897A5089697453 @default.
- W4243923897 hasBestOaLocation W42439238971 @default.
- W4243923897 hasConcept C111113717 @default.
- W4243923897 hasConcept C112705442 @default.
- W4243923897 hasConcept C126322002 @default.
- W4243923897 hasConcept C134018914 @default.
- W4243923897 hasConcept C159641895 @default.
- W4243923897 hasConcept C27016395 @default.
- W4243923897 hasConcept C2776820430 @default.
- W4243923897 hasConcept C2779611605 @default.
- W4243923897 hasConcept C2779888176 @default.
- W4243923897 hasConcept C71924100 @default.
- W4243923897 hasConcept C84393581 @default.
- W4243923897 hasConcept C98274493 @default.
- W4243923897 hasConceptScore W4243923897C111113717 @default.
- W4243923897 hasConceptScore W4243923897C112705442 @default.
- W4243923897 hasConceptScore W4243923897C126322002 @default.
- W4243923897 hasConceptScore W4243923897C134018914 @default.
- W4243923897 hasConceptScore W4243923897C159641895 @default.
- W4243923897 hasConceptScore W4243923897C27016395 @default.
- W4243923897 hasConceptScore W4243923897C2776820430 @default.
- W4243923897 hasConceptScore W4243923897C2779611605 @default.
- W4243923897 hasConceptScore W4243923897C2779888176 @default.
- W4243923897 hasConceptScore W4243923897C71924100 @default.
- W4243923897 hasConceptScore W4243923897C84393581 @default.
- W4243923897 hasConceptScore W4243923897C98274493 @default.
- W4243923897 hasIssue "3" @default.
- W4243923897 hasLocation W42439238971 @default.
- W4243923897 hasLocation W42439238972 @default.
- W4243923897 hasOpenAccess W4243923897 @default.
- W4243923897 hasPrimaryLocation W42439238971 @default.
- W4243923897 hasRelatedWork W108542466 @default.
- W4243923897 hasRelatedWork W1966732677 @default.
- W4243923897 hasRelatedWork W2011102403 @default.
- W4243923897 hasRelatedWork W2064770031 @default.
- W4243923897 hasRelatedWork W2079240737 @default.
- W4243923897 hasRelatedWork W2094193054 @default.
- W4243923897 hasRelatedWork W2095893657 @default.
- W4243923897 hasRelatedWork W2350659269 @default.
- W4243923897 hasRelatedWork W2625601291 @default.
- W4243923897 hasRelatedWork W4238863659 @default.
- W4243923897 hasVolume "20" @default.
- W4243923897 isParatext "false" @default.
- W4243923897 isRetracted "false" @default.
- W4243923897 workType "article" @default.